Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Mesoblast ( (MESO) ) has issued an announcement.
On April 16, 2026, Mesoblast lodged a series of equity-related announcements with the Australian Securities Exchange, including new issue notifications, applications for quotation of securities, changes in directors’ interests and notices of cessation or conversion of unquoted equity. These filings, later reported to the U.S. Securities and Exchange Commission via a Form 6-K dated April 17, 2026, detail adjustments to the company’s capital base and governance-related holdings, including substantial on-market purchases of Mesoblast ADSs and ordinary shares linked to director Gregory George, signaling ongoing capital markets activity and potential alignment of board and shareholder interests.
The most recent analyst rating on (MESO) stock is a Buy with a $35.00 price target. To see the full list of analyst forecasts on Mesoblast stock, see the MESO Stock Forecast page.
Spark’s Take on MESO Stock
According to Spark, TipRanks’ AI Analyst, MESO is a Neutral.
The score is held back primarily by weak financial performance (ongoing losses and cash outflows) and soft technical momentum. These are partially offset by a positive earnings-call outlook, including raised commercial evidence for Ryoncil (strong H1 revenue contribution, 93% gross margin) and clear revenue guidance, while valuation signals are limited due to an unusable P/E and no dividend.
To see Spark’s full report on MESO stock, click here.
More about Mesoblast
Mesoblast Limited is an Australia-based biotechnology company specializing in regenerative medicine therapies, with its securities listed on both the Australian Securities Exchange and in the form of American Depositary Shares in the U.S. The company’s capital structure includes ordinary shares, ADSs, warrants and options, reflecting an active use of equity instruments to fund operations and align management and investor interests.
Average Trading Volume: 262,213
Technical Sentiment Signal: Buy
Current Market Cap: $2.01B
Learn more about MESO stock on TipRanks’ Stock Analysis page.